6505--Insulin (VA-25-00026482)
ID: 36E79725R0018Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/a94bf594db514ca9ae31d2cdb7610952/view
Timeline
    Description

    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0018, aimed at procuring human insulin for various federal agencies, including the Department of Defense and the Bureau of Prisons. The procurement seeks an uninterrupted supply of insulin over a one-year period, with the possibility of extending the contract for four additional one-year options, and includes specific technical requirements such as individual packaging with barcodes and compatibility with automated dispensing units. This initiative underscores the VA's commitment to ensuring a consistent supply of essential medications for federal health services. Interested offerors should monitor the SAM.gov site for updates, as the solicitation will be available electronically around March 4, 2025, with proposals due by March 18, 2025; inquiries can be directed to Contract Specialist Billy Fong at billy.fong@va.gov or by phone at 708-786-4992.

    Point(s) of Contact
    Billy FongContract Specialist
    (708) 786-4992
    billy.fong@va.gov
    Files
    Title
    Posted
    36E79725R0018_1.docx
    The Department of Veterans Affairs (VA) is issuing a Presolicitation Notice for Request for Proposal (RFP) 36E79725R0018, aimed at procuring human insulin for various federal agencies, including the Department of Defense and the Bureau of Prisons. This procurement is unrestricted, with a contract to be awarded for an uninterrupted supply of insulin over a period of one year, extendable by four additional one-year options. The procurement includes specific technical requirements such as individual packaging with barcodes and compatibility with automated dispensing units. The estimated annual usage details for different insulin types are elaborated, including a breakdown of quantities for various packaging sizes. The solicitation will be available electronically around March 4, 2025, with proposals due by March 18, 2025. Potential offerors are advised to monitor the SAM.gov site for updates, as no paper copies will be provided, and inquiries should be directed to the contacting specialist, Billy Fong. This RFP highlights the VA’s commitment to maintaining a consistent supply of essential medications for federal health services.
    Lifecycle
    Title
    Type
    6505--Insulin (VA-25-00026482)
    Currently viewing
    Presolicitation
    Similar Opportunities
    6505--Bevacizumab Injection
    Buyer not available
    The Department of Veterans Affairs (VA) intends to procure Bevacizumab Injections through a Request for Proposal (RFP) designated as 36E79725R0019. This procurement aims to secure an uninterrupted supply of Bevacizumab, a critical pharmaceutical product used in the treatment of various medical conditions, for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The contract will span one year with four additional one-year option periods, and the estimated annual requirements include various package sizes of Bevacizumab, with a total estimated usage of over 100,000 vials. Interested offerors must submit their proposals by March 4, 2025, at 2:30 PM Central Time, and can direct inquiries to Contract Specialist Matthew Poulin at Matthew.Poulin@va.gov or by phone at 708-786-5186.
    6505--Fluticasone Propionate 50 MCG/Spray Soln, Nasal, 16GM
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Fluticasone Propionate 50 MCG/Spray solution, nasal, 16GM, intended for use by various federal agencies including the Department of Defense, Bureau of Prisons, and Indian Health Service. The objective of this procurement is to secure a reliable and uninterrupted supply of this medication for a contract period of one year, with the possibility of four additional one-year extensions. This medication is crucial for treating nasal conditions, and the estimated annual requirement is approximately 5,784,828 bottles. The solicitation will be available electronically on or around February 11, 2025, with a closing date set for February 25, 2025. Interested vendors should direct inquiries to Michael Olszewski at michael.olszewski@va.gov or call 708-786-4966.
    6505--Mycophenolate Mofetil RFP
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Mycophenolate Mofetil capsules and tablets under its Pharmaceutical Prime Vendor Program. The objective of this contract is to establish national pricing for these pharmaceutical products to meet the needs of various government health care facilities, including those under the Department of Defense and Indian Health Service. These medications are critical for patient care within federal health systems, necessitating compliance with FDA standards and the Drug Supply Chain Security Act to ensure safe and reliable distribution. Interested vendors should contact Contract Specialist Amber Zavala at amber.zavala@va.gov for further details, and proposals must include pricing for the base year and four option years as outlined in the solicitation document.
    6515--VISN22 ScriptPro Brand name or Equal
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of the ScriptPro Pharmacy Management System, with an emphasis on brand name or equal products. This solicitation, identified as RFQ 36C26225Q0148, aims to enhance pharmacy automation across various VA medical facilities within VISN 22, ensuring compatibility with existing technology and compliance with specified requirements. The contract will involve the delivery of both hardware and software components essential for improving operational efficiency in veteran healthcare services. Interested vendors must submit their bids by February 18, 2025, at 7:00 AM PST, and can direct inquiries to Contracting Officer Anthony Dela Cruz at anthony.delacruz@va.gov or by phone at 562-766-2284.
    6505--Rituximab and Biosimilars
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Rituximab 10mg/ml and its biosimilars, aimed at establishing a reliable pharmaceutical supply source for government healthcare facilities. Bidders are required to provide unique National Drug Code (NDC) numbers for their products and include a 0.5% Cost Recovery Fee in their pricing, with the contract covering a base year and four optional subsequent years. This procurement is critical for ensuring consistent product availability and pricing based on estimated annual usage, while adhering to FDA regulations and the Drug Supply Chain Security Act (DSCSA) for safety and traceability. Interested suppliers must submit their proposals by March 11, 2025, at 2:30 PM CT, and can contact Contract Specialist Deborah S Fassl at Deborah.Fassl@va.gov for further information.
    Repaglinide
    Buyer not available
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Repaglinide Tablets. The contract will establish a national supply source for the purchase of Repaglinide 0.5MG, 1MG, and 2MG in 100 count bottles. This acquisition will be unrestricted and fully competitive. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. The items listed in the schedule will be purchased by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers through the DLA and VA prime vendor programs. Interested parties should contact Phyllis Daraio for any questions/comments. The projected solicitation date is September 2020.
    6505--Tamsulosin Capsules
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Tamsulosin Hydrochloride capsules as part of its Pharmaceutical Prime Vendor (PPV) Programs. Offerors are required to submit pricing for a base year and four option years, ensuring compliance with FDA standards and providing a unique 11-digit National Drug Code (NDC) for each product. This procurement is vital for maintaining a consistent supply of necessary pharmaceuticals to federal healthcare facilities, adhering to regulatory standards while ensuring availability and pricing stability. Interested parties must submit their offers by February 24, 2025, at 2:30 PM CST, and can contact Contract Specialist Andrew J. Cazares at Andrew.Cazares@va.gov for further information.
    36C25725Q0072 Virtual Pharmacy Service
    Buyer not available
    The Department of Veterans Affairs is seeking contractors to provide Virtual Pharmacy Services for the Amarillo VA Medical Center under solicitation number 36C25725Q0072. The contractor will be responsible for processing medication orders through a secure web-based system, ensuring accuracy and compliance with VA standards, with a contract structure classified as Indefinite Delivery Indefinite Quantity (IDIQ) and a firm-fixed price estimated between $5,800 and $450,000 over five years. This service is crucial for maintaining the quality of healthcare provided to veterans, emphasizing the importance of timely and accurate medication management. Interested contractors must register in the System for Award Management (SAM) and direct inquiries to Contract Specialist Carolyn Reneau at carolyn.reneau@va.gov, with contract performance expected to commence on August 1, 2025.
    6515--766-25-1-400-0207 -Charleston CMOP RESERVOR/SLIM -(VA-25-00028367)
    Buyer not available
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for the procurement of a pharmaceutical item, specifically a reservoir and a slim locking mechanism, to be delivered to the Charleston Consolidated Mail Outpatient Pharmacy (CMOP) facility. The procurement, identified by solicitation number 36C77025Q0092, requires a total quantity of 6,250 units packaged in 10-count boxes, and is categorized as a Small Business Set-Aside under NAICS Code 325413. This procurement is vital for ensuring the availability of necessary pharmaceutical supplies, adhering to federal regulations, and promoting small business participation in government contracting. Interested vendors must submit their proposals, including required documentation, by February 14, 2025, at 3 PM Central Time, and can direct inquiries to Contract Specialist Jennifer Coleman at Jennifer.Coleman4@va.gov or by phone at 913-758-9934.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.